88 related articles for article (PubMed ID: 7636189)
1. Mutational analysis of two DR alpha residues involved in dimers of HLA-DR molecules.
Goodman S; Sawada T; Barbosa JA; Cole B; Pergolizzi R; Silver J; Mellins E; Chang MD
J Immunol; 1995 Aug; 155(3):1210-7. PubMed ID: 7636189
[TBL] [Abstract][Full Text] [Related]
2. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
3. Microvariation creates significant functional differences in the DR3 molecules.
Posch PE; Araujo HA; Creswell K; Praud C; Johnson AH; Hurley CK
Hum Immunol; 1995 Jan; 42(1):61-71. PubMed ID: 7751161
[TBL] [Abstract][Full Text] [Related]
4. Salt bridge residues between I-Ak dimer of dimers alpha-chains modulate antigen presentation.
Yadati S; Nydam T; Demian D; Wade TK; Gabriel JL; Barisas BG; Wade WF
Immunol Lett; 1999 Mar; 67(1):47-55. PubMed ID: 10217205
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.
Lombardi G; Barber L; Aichinger G; Heaton T; Sidhu S; Batchelor JR; Lechler RI
J Immunol; 1991 Sep; 147(6):2034-40. PubMed ID: 1716292
[TBL] [Abstract][Full Text] [Related]
6. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
[TBL] [Abstract][Full Text] [Related]
7. Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation.
Nydam T; Wade TK; Yadati S; Gabriel JL; Barisas BG; Wade WF
Int Immunol; 1998 Aug; 10(8):1237-49. PubMed ID: 9723711
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
Geluk A; Van Meijgaarden KE; Janson AA; Drijfhout JW; Meloen RH; De Vries RR; Ottenhoff TH
J Immunol; 1992 Nov; 149(9):2864-71. PubMed ID: 1383331
[TBL] [Abstract][Full Text] [Related]
9. Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.
Mellins E; Arp B; Singh D; Carreno B; Smith L; Johnson AH; Pious D
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4785-9. PubMed ID: 2112748
[TBL] [Abstract][Full Text] [Related]
10. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
[TBL] [Abstract][Full Text] [Related]
11. Residue 67 in the DRbeta1*0101 and DRbeta1*0103 chains strongly influences antigen presentation and DR-peptide molecular complex conformation.
L'Faqihi FE; Praud C; Yassine-Diab B; Enault G; Lakhdar-Ghazal F; de Préval C; Coppin H
Tissue Antigens; 1998 Jan; 51(1):10-9. PubMed ID: 9459499
[TBL] [Abstract][Full Text] [Related]
12. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
Barber LD; Lechler RI
J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
Olson RR; De Magistris MT; Di Tommaso A; Karr RW
J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
[TBL] [Abstract][Full Text] [Related]
14. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
[TBL] [Abstract][Full Text] [Related]
15. HLA-DPbeta residue 69 plays a crucial role in allorecognition.
Díaz G; Catálfamo M; Coiras MT; Alvarez AM; Jaraquemada D; Nombela C; Sánchez-Pérez M; Arroyo J
Tissue Antigens; 1998 Jul; 52(1):27-36. PubMed ID: 9714471
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
Coppin HL; Avoustin P; Fabron J; Huchenq A; Garnier JM; Thomsen M; De Preval C
J Immunol; 1990 Feb; 144(3):984-9. PubMed ID: 1688595
[TBL] [Abstract][Full Text] [Related]
17. Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule.
Sawada T; Pergolizzi R; Ito K; Silver J; Atkin C; Cole BC; Chang MD
Infect Immun; 1995 Sep; 63(9):3367-72. PubMed ID: 7642264
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
de Koster HS; van Rood JJ; Termijtelen A
Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
[TBL] [Abstract][Full Text] [Related]
19. The impact of DR3 microvariation on peptide binding: the combinations of specific DR beta residues critical to binding differ for different peptides.
Posch PE; Hurley CK; Geluk A; Ottenhoff TH
Hum Immunol; 1996 Sep; 49(2):96-105. PubMed ID: 8872163
[TBL] [Abstract][Full Text] [Related]
20. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
